HomeAgenda

Ascenion GmbH

Other /その他

www.ascenion.de/en/Munich, Germany
19 profile visits

About

Ascenion is an independent technology transfer company focussing on the life sciences.

It is partner to over 30 research organizations, universities and university hospitals in Germany and Europe, including life-science institutes of the Helmholtz and Leibniz Associations, the Charité, the Hannover Medical School and the Medical University of Innsbruck.

The team manages one of Europe’s biggest IP and equity portfolios from academia in the life-sciences field. Commercial opportunities include over 500 technologies and materials available for licensing, acquisition or co-development: novel therapeutic and diagnostic approaches, medical devices, digital health and AI solutions as well as platform technologies, antibodies, animal models and vectors. Ascenion’s equity portfolio of over 35 spin-off companies with several clinical-stage programs offers further attractive investment and partnering opportunities. The ingenuity and scientific excellence of Ascenion’s partners has yielded numerous successful products – including cancer drugs Ixempra and Blinatumomab – and attracted top investors and industry partners from around the globe. Ascenion has so far closed over 1,250 revenue-carrying agreements. 

In 2022 Ascenion initiated the CARMA FUND which invests in early-stage projects and start-ups in the life-science and healthcare sector.

Ascenion has also initiated the pan European showcasing event BioVaria to stimulate deal making and early collaboration between Europe’s academia and the global life-sciences industry. https://www.biovaria.org/

We are looking for licensing and cooperation partners for our technologies: https://www.ascenion.de/en/technology

Social media

Disease Area / 疾患領域

Oncology / がんNeurology & Psychiatry / 中枢神経、精神疾患Infectious diseases / 感染症Immunology / 免疫・炎症Cardiovascular /循環器Rare diseases / 希少疾患Others / その他

Modalities / モダリティ

Small-molecule drug / 低分子医薬Peptide, Protein / ペプチド、タンパクAntibody drug / 抗体医薬Oligonucleotide drug /核酸医薬Gene therapy /遺伝子治療Cell therapy /細胞治療Digital Therapeutics /デジタルセラピューティクスVaccine /ワクチンOthers /その他

Business Type / 業種

Academia, Techtransfer / 学術、技術移転

Additional questions

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Major pharma etc. (Out-licensing purpose) / 大手ファーマ等(アウトライセンスを目的)

Researched disease area / マッチングご希望の疾患領域

Oncology / がんNeurology & Psychiatryy / 中枢神経、精神疾患Infectious diseases / 感染症Immunology / 免疫・炎症Metabolic diseases / 代謝Cardiovascular/ 循環器Rare diseases / 希少疾患

Researched Modality / マッチングご希望のモダリティ

Small-molecule drug/低分子医薬Peptide, Protein / ペプチド、タンパクAntibody drug / 抗体医薬Oligonucleotide drug / 核酸医薬Gene therapy/ 遺伝子治療Cell therapy / 細胞治療Digital Therapeutics デジタルセラピューティクスVaccine / ワクチンOthers / その他

Researched Technologies / マッチングご希望の技術

Biomarkers / バイオマーカーWearable devices / ウェアラブルデバイスAI・Data analysis/ AI・データ分析